| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $91.3M | +432.0% |
| R&D Expense | $163.8M | +23.9% |
| SG&A Expense | $42.4M | +1.1% |
| Operating Income | -$114.9M | +30.1% |
| Pre-tax Income | -$145.2M | +11.2% |
| Income Tax | $3K | +175.0% |
| Net Income | -$145.2M | +11.2% |
| EPS (Basic) | -$5.12 | +15.8% |
| EPS (Diluted) | -$5.12 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.1M | +242.2% |
| Accounts Receivable | $40.8M | +495.0% |
| Current Assets | $431.9M | +6.2% |
| Total Assets | $483.8M | +7.0% |
| Current Liabilities | $45.4M | +21.3% |
| Stockholders' Equity | $70.9M | -19.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$135.3M | -12.0% |
| Capital Expenditures | $358K | -55.6% |
| Investing Cash Flow | $95.4M | -34.1% |
| Financing Cash Flow | $127.1M | +314.3% |
| Free Cash Flow | -$135.7M | -11.6% |
| +15.8% |